Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1954 1
1955 1
1968 1
1969 4
1970 3
1971 1
1972 3
1973 3
1974 2
1975 3
1976 4
1977 5
1978 6
1979 3
1980 1
1981 5
1982 4
1983 4
1984 3
1985 8
1986 4
1987 9
1988 7
1989 1
1990 5
1991 9
1992 10
1993 5
1994 8
1995 10
1996 11
1997 11
1998 16
1999 12
2000 16
2001 13
2002 16
2003 18
2004 25
2005 18
2006 13
2007 14
2008 17
2009 26
2010 30
2011 33
2012 28
2013 50
2014 41
2015 43
2016 45
2017 46
2018 62
2019 56
2020 54
2021 58
2022 27
Text availability
Article attribute
Article type
Publication date

Search Results

861 results
Results by year
Filters applied: . Clear all
Page 1
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Liu J, Mahdi H, Martin L, Matei D, McHale M, McLean K, Miller DS, O'Malley DM, Percac-Lima S, Ratner E, Remmenga SW, Vargas R, Werner TL, Zsiros E, Burns JL, Engh AM. Armstrong DK, et al. J Natl Compr Canc Netw. 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007. J Natl Compr Canc Netw. 2021. PMID: 33545690
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Berek JS, Chen LM, Cristea M, DeRosa M, ElNaggar AC, Gershenson DM, Gray HJ, Hakam A, Jain A, Johnston C, Leath CA III, Liu J, Mahdi H, Matei D, McHale M, McLean K, O'Malley DM, Penson RT, Percac-Lima S, Ratner E, Remmenga SW, Sabbatini P, Werner TL, Zsiros E, Burns JL, Engh AM. Armstrong DK, et al. J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909. doi: 10.6004/jnccn.2019.0039. J Natl Compr Canc Netw. 2019. PMID: 31390583
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
Erratum.
Kirubakaran TG, Grove H, Kent MP, Sandve SR, Baranski M, Nome T, De Rosa MC, Righino B, Johansen T, Otterå H, Sonesson A, Lien SR, Andersen Ø. Kirubakaran TG, et al. Among authors: de rosa mc. Mol Ecol. 2018 Mar;27(6):1520. doi: 10.1111/mec.14530. Mol Ecol. 2018. PMID: 29663587 No abstract available.
Letter to the Editor.
Almaani S, De Rosa M, Rovin BH. Almaani S, et al. Among authors: de rosa m. Kidney Int Rep. 2020 Aug 28;5(11):2121. doi: 10.1016/j.ekir.2020.08.024. eCollection 2020 Nov. Kidney Int Rep. 2020. PMID: 33186416 Free PMC article. No abstract available.
Thyroid function predicts increased cardiovascular risk.
Iaccarino G, De Rosa M, Trimarco B. Iaccarino G, et al. Among authors: de rosa m. Int J Cardiol. 2018 Mar 1;254:338-339. doi: 10.1016/j.ijcard.2017.11.096. Epub 2018 Jan 28. Int J Cardiol. 2018. PMID: 29407115 No abstract available.
861 results